Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.

Kremer, Veronika; Ligtenberg, Maarten A; Zendehdel, Rosa; Seitz, Christina; Duivenvoorden, Annet; Wennerberg, Erik; Colón, Eugenia; Scherman-Plogell, Ann-Helén; Lundqvist, Andreas

Kremer, Veronika; Ligtenberg, Maarten A; Zendehdel, Rosa; Seitz, Christina; Duivenvoorden, Annet; Wennerberg, Erik; Colón, Eugenia; Scherman-Plogell, Ann-Helén; Lundqvist, Andreas.

Afiliação

Kremer V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Ligtenberg MA; Department of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Zendehdel R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Seitz C; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Duivenvoorden A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Wennerberg E; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
Colón E; Department of Oncology-Pathology, Stockholm South General Hospital, Stockholm, Sweden.
Scherman-Plogell AH; Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden.
Lundqvist A; Department of Urology, Stockholm South General Hospital, Stockholm, Sweden.

J Immunother Cancer ; 5(1): 88, 2017 11 06.

Article em En | MEDLINE | ID: mdl-29110706

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Immunother Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google